Skip to main
NGNE
NGNE logo

Neurogene Inc (NGNE)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Neurogene Inc (NGNE) Stock

About Neurogene Inc (NGNE)

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Market cap$281.82M
Yesterday's volume112.72K
Revenue (TTM)$925K
Avg. daily volume274.09K
EBITDA (TTM)-$86.56M
Open$19.51
Price / earnings ratio-4.23x
Yesterday's range$19.51 - $20.62
Debt / equity4.01x
52 week range$6.88 - $74.49
5 year debt / equity-29.3x
Beta (LTM)1.89x
Interest coverage-6883.75x
Dividend & yield$0.00 (0.00%)
Current ratio21.03x
Ex-dividend date
Next earningsJun 28, 2024
Dividend payable date

Neurogene Inc Stock Rating

What analysts recommend for NGNE stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 13, 2025, the market cap for NGNE stock is $281.82M

The current P/E ratio for NGNE stock is -4.23

The 52-week high for NGNE stock is $74.49. The current NGNE stock price $undefined is 100.00% below its 52-week high

The 52-week low for NGNE stock is $6.88. The current NGNE stock price $undefined has increased 100.00% from its 52-week low

No, the NGNE stock does not pay dividends to its shareholders

The target price for NGNE stock is $45.40 based on the average of what a group of analyst think NGNE stock could be worth at a future date. This is not a prediction by Public.com

How to buy NGNE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NGNE stock

    Navigate to the Explore page. Then, type NGNE into the search bar. When you see NGNE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NGNE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Neurogene Inc Stock Earnings

The value each NGNE share was expected to gain vs. the value that each NGNE share actually gained.

Neurogene Inc (NGNE) reported Q1 2024 earnings per share (EPS) of -$1, beating estimates of -$1.13 by 11.50%. In the same quarter last year, Neurogene Inc's earnings per share (EPS) was $0. Neurogene Inc is expected to release next earnings on 06/28/2024, with an earnings per share (EPS) estimate of -$1.30.

Buy Neurogene Inc (NGNE) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.